Page 16 - Serum Institute Of India

WHO head wants Covid-19 vaccine patents waived to increase supply

The head of the World Health Organization called for patent rights to be waived until the end of the pandemic so that vaccine supplies can be dramatically increased

US export curbs can limit Covid shot production, availability: Poonawalla

The production of coronavirus vaccines and scaling up global availability could be seriously limited due to ban on exports of critical raw materials by the US, according to SII CEO Adar Poonawalla

US ban on export of critical raw materials to limit vaccine supply: Serum

SII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the Novavax shot

India Coronavirus Dispatch: New computational tool to track Covid mutations

Parents more ready to send kids to school, trial candidates wonder if they got vaccine or placebo, Antibodies appear faster if exposed to virus earlier-news relevant to India's fight against Covid-19

Decoded: How Covid-19 vaccine efficacy helps to get an idea of protection

Efficacy of a vaccine means its ability to stimulate immunity in a person who has received the shot

Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results

Covaxin demonstrates significant immunogenicity against the rapidly emerging variants, says Bharat Biotech CMD

UK to receive 10 mn AstraZeneca vaccine doses from India's Serum Institute

SII, the world's largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries

COVAX vaccine programme to deliver 237 mn doses to 142 nations by end-May

The timeline for the delivery of doses, made by AstraZeneca and by India's Serum Institute, will be split into separate two-month schedules, COVAX said in a statement

European Union drug regulator audits manufacturing site of Serum Institute

AstraZeneca Chief Executive (CEO) Pascal Soriot has indicated that the company may look at factories outside of the EU to meet the supply commitments.

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

PM taking indigenous vaccine should remove doubts on side-effects: Vardhan

Prime Minister Narendra Modi taking an indigenously developed COVID-19 vaccine should remove all doubts that people have about its side-effects, Harsh Vardhan said

Chinese hackers targeted Serum, Bharat Biotech, says security firm

Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than 60 per cent of all vaccines sold in the world

Top headlines: PM Modi receives Covid jab; ATF price raised by a steep 6.5%

Business Standard brings you top news of the evening

Serum's Poonawalla apprises Amit Shah about Covid-19 vaccine rollout

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country. "It was my honour to brief you today, Shri Hon'ble @AmitShah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India," Poonawalla said in a tweet. In January, thecountry's drugs regulator had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. Apart from making efforts to meet the requirements of India, SII, the world's largest vaccine maker, is also trying its best to balance the needs of the rest of the world.

'Tie-up with Serum Institute key to mass production of Covid-19 vaccines'

Located in the city of Pune in Maharashtra, the SII is the world''s largest vaccine manufacturer by volume

Expert panel asks DRL to come back with more data on Sputnik safety

DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months

Serum Institute to export Covid-19 vaccine to 25-30 countries on Tuesday

Bharat Bio says keen to follow, have capacity of 40 mn doses a month

Poonawalla urges countries to be patient, Serum to prioritise India needs

Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added

Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX

Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.

Covid-19 vaccination: Serum Institute to gain from G7's boost to COVAX

The immediate contribution will be $2 billion. More than 180 nations are yet to administer a single dose of the Covid vaccine